AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 151 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $460,594 | -18.2% | 20,052 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $563,060 | -19.9% | 20,052 | -19.4% | 0.00% | -20.0% |
| Q3 2022 | $703,000 | +297.2% | 24,870 | +675.2% | 0.01% | +400.0% |
| Q2 2021 | $177,000 | +7.9% | 3,208 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $164,000 | +368.6% | 3,175 | +292.5% | 0.00% | – |
| Q4 2020 | $35,000 | +25.0% | 809 | 0.0% | 0.00% | – |
| Q3 2020 | $28,000 | -34.9% | 809 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | +48.3% | 809 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -94.8% | 809 | -92.3% | 0.00% | -100.0% |
| Q3 2016 | $555,000 | +26.1% | 10,510 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $440,000 | -29.4% | 10,510 | -31.5% | 0.00% | -33.3% |
| Q1 2016 | $623,000 | +1846.9% | 15,353 | +3046.1% | 0.00% | – |
| Q4 2015 | $32,000 | -34.7% | 488 | -6.3% | 0.00% | – |
| Q1 2015 | $49,000 | +2350.0% | 521 | +740.3% | 0.00% | – |
| Q1 2014 | $2,000 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |